WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003053330) USE OF OXINDOLE DERIVATIVES IN THE TREATMENT OF DEMENTIA RELATED DISEASES, ALZHEIMER’S DISEASE AND CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTHASE KINASE-3
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/053330    International Application No.:    PCT/SE2002/002373
Publication Date: 03.07.2003 International Filing Date: 18.12.2002
Chapter 2 Demand Filed:    30.06.2003    
IPC:
C07D 217/22 (2006.01), C07D 401/04 (2006.01), C07D 403/04 (2006.01), C07D 495/04 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
BERG, Stefan [SE/SE]; (SE) (For US Only).
BHAT, Ratan [US/SE]; (SE) (For US Only).
EMPFIELD, James [US/US]; (US) (For US Only).
HELLBERG, Sven [SE/SE]; (SE) (For US Only).
KLIMAS, Michael [US/US]; (US) (For US Only).
WOODS, James [US/US]; (US) (For US Only)
Inventors: BERG, Stefan; (SE).
BHAT, Ratan; (SE).
EMPFIELD, James; (US).
HELLBERG, Sven; (SE).
KLIMAS, Michael; (US).
WOODS, James; (US)
Agent: ASTRAZENECA AB; Global Intellectual Property, S-151 85 Södertälje (SE)
Priority Data:
0104340-5 20.12.2001 SE
Title (EN) USE OF OXINDOLE DERIVATIVES IN THE TREATMENT OF DEMENTIA RELATED DISEASES, ALZHEIMER’S DISEASE AND CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTHASE KINASE-3
(FR) NOUVEAUX COMPOSÉS
Abstract: front page image
(EN)The present invention relates to new compounds of formula (I) wherein Y, P, R1, R2, R3, n, m are defined as in claim 1, a process for their preparation and new intermediates used therein, pharmaceutical composition containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the prevention and/or treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3.
(FR)Cette invention, qui a trait à de nouveaux composés correspondant à la formule (I), formule dans laquelle Y, P, R1, R2, R3, n et m sont tels que définis dans la revendication N°1, concerne également un procédé de préparation de ces composés ainsi que les nouveaux intermédiaires dont il est fait usage à cet effet. Elle porte, de surcroît, sur une composition pharmaceutique contenant ces composés actifs du point de vue thérapeutique ainsi que sur leurs applications thérapeutiques, notamment en matière de prévention et/ou de traitement de troubles liés à la démence, de la maladie d'Alzheimer et d'états pathologiques associés à la glycogène synthase kinase-3.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)